Article Information
History
- December 2, 2020.
Article Versions
- Version 1 (August 14, 2020 - 09:54).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Aymric Kisserli1,2,
- Nathalie Schneider3,
- Sandra Audonnet4,
- Thierry Tabary2,5,
- Antoine Goury6,
- Joel Cousson6,
- Rachid Mahmoudi7,8,
- Firouze Bani-Sadr6,
- Lukshe Kanagaratnam8,9,
- Damien Jolly8,9 and
- Jacques HM Cohen2,*
- 1Oncogeriatric Coordination Unit, Rheims University Hospital, Rheims, France
- 2Nanosciences Research Laboratory LRN EA 4682, University of Rheims Champagne-Ardenne, Rheims, France
- 3Biochemistry, Pharmacology and Toxicology Unit, Rheims University Hospital, Rheims, France
- 4URCACyt, Flow Cytometry Technical Platform, University of Rheims Champagne-Ardenne, Rheims, France
- 5Immunology Laboratory, Rheims University Hospital, Rheims, France
- 6Medical-Surgical ICU, Rheims University Hospital, Rheims, France
- 7Department of Internal Medicine and Geriatrics, Rheims University Hospital, Rheims, France
- 8Aging and Fragility Unit EA 3797, University of Rheims Champagne-Ardenne, Rheims, France
- 9Research Promotion and Support Unit, Rheims University Hospital, Rheims, France
- ↵*Correspondence:
Jacques H. M. Cohen, Laboratoire de Recherche en Nanosciences LRN EA4682 Université de Reims Champagne-Ardenne, 51100 Reims, France ; e-mail : jacques.cohen{at}univreims. fr; tel : +33 611936745.